DATIX, a leader in the development of risk management and patient safety software for the healthcare sector, has undergone a management buy-out backed by the mid-market private equity firm Bowmark Capital. Clearwater International advised Bowmark on the deal. Founded in 1986, London-based DATIX is the market leader in the UK, with its software installed in more than 70 per cent of National Health Service hospitals. Its products are also used by major healthcare providers worldwide. DATIX’s annual turnover has grown by more than 20 per cent per annum over the past three years. Joint managing directors Jonathan Hazan and Daniel Hazan led the buy-out. Founder Brian Capstick will remain an investor in the company and will become a non-executive director.
“DATIX has spent 20 years developing and refining its software based on a deep understanding of its clients’ needs. Its enviable reputation for quality, reliability and functionality will underpin the management’s strategy to develop the business further in the UK and internationally.”
“Risk management systems are an important tool by which healthcare institutions can monitor quality of care, control costs and minimise damage to their reputation. They can also help hospitals to meet regulatory requirements. Worldwide concern about patient safety means there is a growing market for DATIX’s products.”